{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:56:24Z","timestamp":1792587384431,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL 118018"],"award-info":[{"award-number":["R01 HL 118018"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jaccao.2021.01.011","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T21:38:49Z","timestamp":1616103529000},"page":"1-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["BSE and BCOS Guideline for Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines and\/or Trastuzumab"],"prefix":"10.1016","volume":"3","author":[{"given":"Rebecca","family":"Dobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun K.","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Ky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Marwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Harkness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Steeds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Oxborough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Adlam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susannah","family":"Stanway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0245-7090","authenticated-orcid":false,"given":"Charlotte","family":"Manisty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Harbinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Lyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel X.","family":"Augustine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccao.2021.01.011_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40959-016-0014-2","article-title":"Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic","volume":"2","author":"Barros-Gomes","year":"2016","journal-title":"Cardio-Oncology"},{"key":"10.1016\/j.jaccao.2021.01.011_bib2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ihj.2017.05.006","article-title":"Cardio-oncology \u2013 a new subspecialty with collaboration at its heart","volume":"69","author":"Ghosh","year":"2017","journal-title":"Indian Heart J"},{"key":"10.1016\/j.jaccao.2021.01.011_bib3","doi-asserted-by":"crossref","first-page":"G59","DOI":"10.1530\/ERP-20-0026","article-title":"A\u00a0practical guideline for performing a comprehensive transthoracic echocardiogram in adults: the British Society of Echocardiography minimum dataset","volume":"7","author":"Robinson","year":"2020","journal-title":"Echo Res Pract"},{"key":"10.1016\/j.jaccao.2021.01.011_bib4","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.jacc.2017.09.1096","article-title":"Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1","volume":"70","author":"Chang","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2217\/fon.14.184","article-title":"Pertuzumab-induced cardiotoxicity: safety compared with trastuzumab","volume":"11","author":"Sendur","year":"2015","journal-title":"Futur Oncol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-017-0034-x","article-title":"Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy","volume":"1","author":"Han","year":"2017","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib7","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1161\/CIRCRESAHA.112.267286","article-title":"Neuregulin in cardiovascular development and disease","author":"Odiete","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.jaccao.2021.01.011_bib8","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1200\/JCO.2005.13.300","article-title":"Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment","volume":"23","author":"Ewer","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/eurjhf\/hfq213","article-title":"Cardiovascular side effects of cancer therapies: a position statement from the Heart\u00a0Failure Association of the European Society of Cardiology","volume":"13","author":"Eschenhagen","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jaccao.2021.01.011_bib10","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2021.01.011_bib11","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/ijc.29468","article-title":"Cardiovascular disease in Adult Life after Childhood Cancer in Scandinavia: a population-based cohort study of 32,308 one-year survivors","volume":"137","author":"Gudmundsdottir","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaccao.2021.01.011_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jamacardio.2019.5586","article-title":"Long-term cardiopulmonary consequences of treatment-induced cardiotoxicity in survivors of ERBB2-positive breast cancer","volume":"5","author":"Yu","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2012.09.035","article-title":"Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy","volume":"61","author":"Thavendiranathan","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib14","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/ejhf.1920","volume":"22","author":"Lyon","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jaccao.2021.01.011_bib15","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/ejhf.1957","article-title":"Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart\u00a0Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the","volume":"22","author":"\u010celutkien\u0117","year":"2020","journal-title":"European Society of Cardiology (ESC) Eur J Heart Fail"},{"key":"10.1016\/j.jaccao.2021.01.011_bib16","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib17","first-page":"345","article-title":"Modified routine cardiac imaging surveillance of adult cancer patients and survivors during the COVID-19 pandemic","volume":"2","author":"Calvillo-Arg\u00fcelles","year":"2020","journal-title":"J\u00a0Am Coll Cardiol CardioOnc"},{"key":"10.1016\/j.jaccao.2021.01.011_bib18","article-title":"Cardio-oncology in the era of the COVID-19 pandemic and beyond","volume":"9","author":"Addison","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jaccao.2021.01.011_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000774","article-title":"Cardiotoxicity: precision medicine with imprecise definitions","volume":"5","author":"Chung","year":"2018","journal-title":"Open Heart"},{"key":"10.1016\/j.jaccao.2021.01.011_bib20","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jcmg.2018.03.025","article-title":"Contemporary role of echocardiography for clinical decision making in patients during and after cancer therapy","author":"Liu","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jaccao.2021.01.011_bib21","doi-asserted-by":"crossref","first-page":"vii155","DOI":"10.1093\/annonc\/mds293","article-title":"Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines","volume":"Suppl 7","author":"Curigliano","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib22","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1200\/JCO.2015.64.5515","article-title":"Cardiac surveillance guidelines for trastuzumab-containing therapy in early-stage breast cancer: getting to the heart of the matter","volume":"34","author":"Dang","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib23","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1200\/JCO.2014.58.9465","article-title":"Cardiac monitoring during adjuvant trastuzumab-based chemotherapy among older patients with breast cancer","volume":"33","author":"Chavez-MacGregor","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10549-019-05191-2","article-title":"Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study","volume":"175","author":"Lynce","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jaccao.2021.01.011_bib25","first-page":"1","article-title":"Safety of continuing trastuzumab despite mild cardiotoxicity","volume":"1","author":"Leong","year":"2019","journal-title":"J\u00a0Am Coll Cardiol CardioOnc"},{"key":"10.1016\/j.jaccao.2021.01.011_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","article-title":"Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib27","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/ERP-19-0050","article-title":"Normal reference intervals for cardiac dimensions and function for use in echocardiographic practice: a guideline from the British Society of Echocardiography","volume":"7","author":"Harkness","year":"2020","journal-title":"Echo Res Pract"},{"key":"10.1016\/j.jaccao.2021.01.011_bib28","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/ehjci\/jex033","article-title":"2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility","volume":"18","author":"Santoro","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jaccao.2021.01.011_bib29","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jcmg.2018.01.015","article-title":"Abnormalities in 3-dimensional left ventricular mechanics with anthracycline chemotherapy are associated with systolic and diastolic dysfunction","volume":"11","author":"Zhang","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jaccao.2021.01.011_bib30","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jcmg.2018.07.005","article-title":"Research to practice: assessment of left ventricular global longitudinal strain for surveillance of cancer chemotherapeutic-related cardiac dysfunction","volume":"11","author":"Yang","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jaccao.2021.01.011_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jaccao.2021.01.011_bib32","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.echo.2019.08.012","article-title":"Similarities and differences in left ventricular size and function among races and nationalities: results of the World Alliance Societies of Echocardiography Normal Values study","volume":"32","author":"Asch","year":"2019","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jaccao.2021.01.011_bib33","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","author":"Plana","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jaccao.2021.01.011_bib34","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jacc.2020.11.020","article-title":"SUCCOUR Investigators. Strain-guided management of potentially cardiotoxic cancer therapy","volume":"77","author":"Thavendiranathan","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib35","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","article-title":"Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review","author":"Thavendiranathan","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ejhf.8","article-title":"Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy","volume":"16","author":"Kang","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jaccao.2021.01.011_bib37","first-page":"977","article-title":"Echocardiographic parameters of left ventricular size and function as predictors of symptomatic heart failure in patients with a left ventricular ejection fraction of 50-59% treated with anthracyclines","volume":"16","author":"Mousavi","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jaccao.2021.01.011_bib38","first-page":"677","article-title":"Strain imaging in cardio-oncology","volume":"2","author":"Liu","year":"2020","journal-title":"J\u00a0Am Coll Cardiol CardioOnc"},{"key":"10.1016\/j.jaccao.2021.01.011_bib39","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/europace\/eux027","article-title":"Is echocardiography valid and reproducible in patients with atrial fibrillation? A systematic review","volume":"19","author":"Kotecha","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.jaccao.2021.01.011_bib40","first-page":"1","article-title":"Early and quantitative assessment of myocardial deformation in essential hypertension patients by using cardiovascular magnetic resonance feature tracking","volume":"10","author":"Liu","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaccao.2021.01.011_bib41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/oxfordjournals.eurheartj.a015273","article-title":"Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function","volume":"18","author":"Otterstad","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2021.01.011_bib42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.echo.2017.10.010","article-title":"Intervendor consistency and accuracy of left ventricular volume measurements using three-dimensional echocardiography","volume":"31","author":"Muraru","year":"2018","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jaccao.2021.01.011_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/echo.12331","article-title":"Left ventricular ejection fraction and volumes: it depends on the imaging method","volume":"31","author":"Wood","year":"2014","journal-title":"Echocardiography"},{"key":"10.1016\/j.jaccao.2021.01.011_bib44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.15420\/cfr.2017:14.1","article-title":"The role of automated 3D echocardiography for left ventricular ejection fraction assessment","volume":"3","author":"Spitzer","year":"2017","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.jaccao.2021.01.011_bib45","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/ehjci\/jex182","article-title":"Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017","volume":"18","author":"Senior","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jaccao.2021.01.011_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1530\/ERP-18-0003","article-title":"What is the minimum change in left ventricular ejection fraction, which can be measured with contrast echocardiography?","volume":"5","author":"Suwatanaviroj","year":"2018","journal-title":"Echo Res Pract"},{"key":"10.1016\/j.jaccao.2021.01.011_bib47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcmg.2019.07.018","article-title":"Comprehensive assessment of changes in left ventricular diastolic function with contemporary breast cancer therapy","volume":"13","author":"Upshaw","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jaccao.2021.01.011_bib48","author":"Mathew"},{"key":"10.1016\/j.jaccao.2021.01.011_bib49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jaccao.2021.01.011_bib50","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1161\/CIRCULATIONAHA.106.647172","article-title":"Role of tissue Doppler and strain echocardiography in current clinical practice","volume":"116","author":"Abraham","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2021.01.011_bib51","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/heart.89.12.1377","article-title":"Clinical applications of tissue Doppler imaging: a promise fulfilled","volume":"89","author":"Marwick","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.jaccao.2021.01.011_bib52","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1530\/ERP-19-0020","article-title":"Practical tips and tricks in measuring strain, strain rate and twist for the left and right ventricles","volume":"6","author":"Johnson","year":"2019","journal-title":"Echo Res Pract"},{"key":"10.1016\/j.jaccao.2021.01.011_bib53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/ERP-16-0022","article-title":"Global longitudinal strain: a useful everyday measurement?","volume":"3","author":"King","year":"2016","journal-title":"Echo Res Pract"},{"key":"10.1016\/j.jaccao.2021.01.011_bib54","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12947-019-0168-9","article-title":"Global longitudinal strain is a more reproducible measure of left ventricular function than ejection fraction regardless of echocardiographic training","volume":"17","author":"Karlsen","year":"2019","journal-title":"Cardiovasc Ultrasound"},{"key":"10.1016\/j.jaccao.2021.01.011_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jcmg.2017.01.027","article-title":"Variability and reproducibility of segmental longitudinal strain measurement: a report from the EACVI-ASE Strain Standardization Task Force","volume":"11","author":"Mirea","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jaccao.2021.01.011_bib56","first-page":"707","article-title":"Intervendor consistency and reproducibility of left ventricular 2D global and regional strain with two different high-end ultrasound systems","volume":"18","author":"Shiino","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jaccao.2021.01.011_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjci\/jeu184","article-title":"Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging","volume":"16","author":"Voigt","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jaccao.2021.01.011_bib58","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/clc.22672","article-title":"The influence of chemotherapy on the right ventricle: did we forget something?","volume":"40","author":"Tadic","year":"2017","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib59","first-page":"13","article-title":"Early Detection and prediction of anthracycline-induced right ventricular cardiotoxicity by 3-dimensional echocardiography","volume":"2","author":"Zhao","year":"2020","journal-title":"J\u00a0Am Coll Cardiol CardioOnc"},{"key":"10.1016\/j.jaccao.2021.01.011_bib60","doi-asserted-by":"crossref","first-page":"G19","DOI":"10.1530\/ERP-19-0051","article-title":"Echocardiographic assessment of the right heart in adults: a practical guideline from the British Society of Echocardiography","volume":"7","author":"Zaidi","year":"2020","journal-title":"Echo Res Pract"},{"key":"10.1016\/j.jaccao.2021.01.011_bib61","doi-asserted-by":"crossref","first-page":"G11","DOI":"10.1530\/ERP-17-0071","article-title":"Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of Echocardiography","volume":"5","author":"Augustine","year":"2018","journal-title":"Echo Res Pract"},{"key":"10.1016\/j.jaccao.2021.01.011_bib62","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jcmg.2018.06.003","article-title":"Multi-modality imaging in the assessment of cardiovascular toxicity in the cancer patient","volume":"11","author":"Plana","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jaccao.2021.01.011_bib63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11864-019-0672-z","article-title":"Advanced imaging modalities to monitor for cardiotoxicity","volume":"20","author":"Seraphim","year":"2019","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib64","doi-asserted-by":"crossref","first-page":"20140831","DOI":"10.1259\/bjr.20140831","article-title":"Variability in cardiac MR measurement of left ventricular ejection fraction, volumes and mass in healthy adults: defining a significant change at 1 year","volume":"88","author":"Moody","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11864-019-0645-2","article-title":"Applications of cardiac computed tomography in the cardio-oncology population","volume":"20","author":"Layoun","year":"2019","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib66","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/jeaa351","article-title":"Cardiac computed tomography in cardio-oncology: an update on recent clinical applications","author":"Rosmini","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"Suppl 35","key":"10.1016\/j.jaccao.2021.01.011_bib67","doi-asserted-by":"crossref","first-page":"S4282","DOI":"10.21037\/jtd.2018.08.15","article-title":"Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicity","volume":"10","author":"Michel","year":"2018","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jaccao.2021.01.011_bib68","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/01.CIR.0000130926.51766.CC","article-title":"Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy","volume":"109","author":"Cardinale","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2021.01.011_bib69","first-page":"863","article-title":"Prognostic role of troponin and natriuretic peptides as biomarkers for deterioration of left ventricular ejection fraction after chemotherapy","volume":"10","author":"Stachowiak","year":"2014","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.jaccao.2021.01.011_bib70","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/annonc\/mdf170","article-title":"Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy","volume":"13","author":"Cardinale","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib71","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1373\/clinchem.2005.050153","article-title":"N-terminal pro-B-type natriuretic peptide after high-dose chemotherapy: a marker predictive of cardiac dysfunction?","volume":"51","author":"Sandri","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.jaccao.2021.01.011_bib72","article-title":"Changes in cardiovascular biomarkers with breast cancer therapy and associations with cardiac dysfunction","volume":"9","author":"Demissei","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jaccao.2021.01.011_bib73","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1093\/eurheartj\/ehz460","article-title":"Development and validation of a multivariable prediction model for major adverse cardiovascular events after early stage breast cancer: a population-based cohort study","volume":"40","author":"Abdel-Qadir","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2021.01.011_bib74","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/eurheartj\/ehy453","article-title":"Cardio-oncology services: Rationale, organization, and implementation: a report from the ESC Cardio-Oncology council","volume":"40","author":"Lancellotti","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2021.01.011_bib75","doi-asserted-by":"crossref","first-page":"C11","DOI":"10.12968\/hmed.2017.78.1.C11","article-title":"Cardio-oncology","volume":"78","author":"Ghosh","year":"2017","journal-title":"Br J Hosp Med"},{"key":"10.1016\/j.jaccao.2021.01.011_bib76","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","article-title":"Anthracycline-induced cardiomyopathy. clinical relevance and response to pharmacologic therapy","volume":"55","author":"Cardinale","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib77","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2021.01.011_bib78","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2021.01.011_bib79","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib80","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.echo.2013.02.008","article-title":"Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity","volume":"26","author":"Negishi","year":"2013","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jaccao.2021.01.011_bib81","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/eurheartj\/ehw022","article-title":"Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2\u00a0\u00d7 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol","volume":"37","author":"Gulati","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2021.01.011_bib82","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1200\/JCO.2016.68.7830","article-title":"Multidisciplinary approach to novel therapies in cardio-oncology research (MANTICORE 101-Breast): a randomized trial for the prevention of trastuzumab-associated cardiotoxicity","volume":"35","author":"Pituskin","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib83","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2018.02.049","article-title":"Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial","volume":"71","author":"Avila","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.01.011_bib84","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11739-012-0794-9","article-title":"Role of renal function on the development of cardiotoxicity associated with trastuzumab-based adjuvant chemotherapy for early breast cancer","volume":"7","author":"Russo","year":"2012","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jaccao.2021.01.011_bib85","first-page":"831","article-title":"Canadian Cardiovascular Society guidelines for evaluation and management of cardiovascular complications of cancer therapy","volume":"32","author":"Virani","year":"2016","journal-title":"Can J Cardiol"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087321000235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087321000235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:54:23Z","timestamp":1762973663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087321000235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2666087321000235"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2021.01.011","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BSE and BCOS Guideline for Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines and\/or Trastuzumab","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2021.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of the American College of Cardiology Foundation and BioScientifica Ltd. on behalf of British Society of Echocardiography.","name":"copyright","label":"Copyright"}]}}